The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. NeuroSense Therapeutics Ltd’s current trading price is -16.00% away from its 52-week high, while its distance from the 52-week low is 146.09%. The stock’s price range for this period has been between $0.51 and $1.50 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.84 million for the day, a number notably higher than the average daily volume of 0.14 million over the last three months.
In terms of market performance, NeuroSense Therapeutics Ltd had a fairly even. The highest value for the stock in the past year was $1.50 on 07/02/24, and the lowest value was recorded at $0.51 on 07/19/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
NeuroSense Therapeutics Ltd (NRSN) has experienced a quarterly rise of 9.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.23M and boasts a workforce of 15 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0918, with a change in price of +0.3763. Similarly, NeuroSense Therapeutics Ltd recorded 203,023 in trading volume during the last 100 days, posting a change of +42.58%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NRSN stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.00.
NRSN Stock Stochastic Average
NeuroSense Therapeutics Ltd’s raw stochastic average for the past 50 days is presently 75.93%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 71.74%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 77.45% and 75.21%, respectively.
NRSN Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 5.00% this year. Over the last six months, there has been a stronger performance of -2.33%. The price of NRSN fallen by 18.87% during the last 30 days period. For the last 5-days stocks have improved 22.22%.
